Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis
Ulrike Peters(University of Washington), David Levine(University of Washington), Todd L. Edwards(Nashville VA Medical Center), David V. Conti(University of Southern California), Lin Chen(University of Chicago), Simon G. Coetzee(University of Southern California), Steven Gallinger(Ontario Institute for Cancer Research), Jenny Chang‐Claude(Universität Hamburg), John L. Hopper(The University of Melbourne), Aaron K. Aragaki(Fred Hutch Cancer Center), Sébastien Küry(Centre National de la Recherche Scientifique), Keith R. Curtis(Fred Hutch Cancer Center), Tabitha A. Harrison(University of Washington), John A. Baron(University of North Carolina at Chapel Hill), Michael Hoffmeister(German Cancer Research Center), Edward L. Giovannucci(Massachusetts Department of Public Health), Gerhard A. Coetzee(Van Andel Institute), Fredrick R. Schumacher(Harvard University), Richard B. Hayes(New York University), Carolyn M. Hutter(National Human Genome Research Institute), Sun Ha Jee(Yonsei University), Robert W. Haile(University of Southern California), Mathieu Lemire(Ontario Institute for Cancer Research), Cathy C. Laurie(University of Washington), Charles S. Fuchs(University of Southern California), Katja Butterbach(German Cancer Research Center), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Peter T. Campbell(Mount Sinai Hospital), Thomas J. Hudson(Ontario Institute for Cancer Research), Shuo Jiao(Northwest A&F University), Sonja I. Berndt(Department of Health and Human Services), Andrew T. Chan(Harvard University), Stephen B. Gruber(City Of Hope National Medical Center), David Duggan(Translational Genomics Research Institute), Andrea Z. LaCroix(Human Longevity (United States)), Hermann Brenner(Universidad de Granada), Stephanie M. Gogarten(University of Washington), Bette J. Caan(Kaiser Permanente), Christopher S. Carlson(Fred Hutch Cancer Center), Graham Casey(Cleveland Clinic Lerner College of Medicine), Stéphane Bezieau(Centre Hospitalier Universitaire de Nantes), Mark A. Jenkins(The University of Melbourne), Stephen J. Chanock(National Cancer Institute), Wei–Hua Jia(Sun Yat-sen University), Laurence N. Kolonel(Cancer Center of Hawaii), Rebecca D. Jackson(The Ohio State University), David J. Hunter(Zhujiang Hospital), Cecelia Laurie(University of Washington), Brian E. Henderson(Trinity College Dublin), Charles Kooperberg(Fred Hutch Cancer Center)
Cited by 341
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
|American Journal of Clinical Nutrition|2006|2.4k